{
  "ticker": "SPRY",
  "company_name": "ARS Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05363670",
      "title": "Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Asthma",
      "start_date": "2022-07-28",
      "completion_date": "2024-02-02",
      "enrollment": 0,
      "sponsor": "ARS Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT04930900",
      "title": "Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Upper Respiratory Tract Infection",
      "start_date": "2021-08-09",
      "completion_date": "2022-07-25",
      "enrollment": 0,
      "sponsor": "ARS Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT06834165",
      "title": "Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy",
      "status": "RECRUITING",
      "phase": "PHASE4",
      "condition": "Allergic Reactions",
      "start_date": "2025-05-20",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "ARS Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT05496465",
      "title": "Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Urticaria",
      "start_date": "2022-07-28",
      "completion_date": "2024-02-29",
      "enrollment": 0,
      "sponsor": "ARS Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT06927999",
      "title": "An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Urticaria Chronic",
      "start_date": "2025-07-09",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "ARS Pharmaceuticals, Inc."
    }
  ],
  "summary": {
    "total_trials": 5,
    "by_phase": {
      "PHASE2": 3,
      "PHASE1": 1,
      "PHASE4": 1
    },
    "by_status": {
      "COMPLETED": 3,
      "RECRUITING": 2
    },
    "active_trials": 2,
    "completed_trials": 3,
    "conditions": [
      "Allergic Reactions",
      "Asthma",
      "Upper Respiratory Tract Infection",
      "Urticaria",
      "Urticaria Chronic"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:44:56.641670",
    "search_query": "ARS Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=ARS+Pharmaceuticals,+Inc."
  }
}